Oxford study: Existing Covid-19 vaccines may protect against Brazilian variant

Oxford study: Existing Covid-19 vaccines may protect against Brazilian variant
Oxford study: Existing Covid-19 vaccines may protect against Brazilian variant

Hello and welcome to the details of Oxford study: Existing Covid-19 vaccines may protect against Brazilian variant and now with the details

Nevin Al Sukari - Sana'a - Small bottles labelled with a ‘VaccineCovid-19 sticker and a medical syringe are seen in this illustration taken April 10, 2020. — Reuters pic

Subscribe to our Telegram channel for the latest updates on news you need to know.


LONDON, March 18 — Existing vaccines may protect against the Brazilian variant of the coronavirus, according to a University of Oxford study which also highlighted how a variant first found in South Africa poses the biggest headache for vaccine makers.

Coronavirus variants with specific mutations to the spike protein are of concern because scientists worry they will reduce the efficacy of vaccines, as well as immunity gained from prior infection.

The scientists used blood samples from people with antibodies generated by both Covid-19 infection and the Oxford/AstraZeneca and Pfizer/BioNTech vaccines that are being rolled out in Britain.

The data showed a nearly three-fold reduction in the level of virus neturalisation by antibodies generated by the vaccines for the P.1 Brazil variant — similar to the reduction seen with the variant first identified in Kent, Britain.

“These data suggest that natural- and vaccine-induced antibodies can still neutralise these variants, but at lower levels,” it said. “Importantly, the P1 ‘Brazilian’ strain may be less resistant to these antibodies than first feared.”

The variant first identified in South Africa triggered a much larger reduction in virus neutralisation, with a 9-fold reduction in Oxford/AstraZeneca’s vaccine, and a 7.6-fold reduction for Pfizer/BioNTech.

Last month, South Africa put use of AstraZeneca’s shot on hold after data showed it gave minimal protection against mild-to-moderate infection cause by the country’s dominant variant.

The authors of the study said that developing vaccines against the South Africa variant, known as B.1.351, should be the “greatest priority for vaccine developers globally”.

Andrew Pollard, chief investigator of the Oxford University vaccine trial, said the study provided “new insights that help us be prepared to respond to further challenges to our health from the pandemic virus, if we need to do so”.

The study was released on a pre-print server, and had not been peer-reviewed. — Reuters

These were the details of the news Oxford study: Existing Covid-19 vaccines may protect against Brazilian variant for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Abu Dhabi art gallery owner has a sideline business: trading COVID-19 vaccines
NEXT Youth join mainstream as India unveils development initiatives in Jammu and Kashmir